Literature DB >> 23619318

Predictors of operative mortality in cardiac surgical patients with prolonged intensive care unit duration.

Damien J LaPar1, Jacob R Gillen, Ivan K Crosby, Robert G Sawyer, Christine L Lau, Irving L Kron, Gorav Ailawadi.   

Abstract

BACKGROUND: Several systems have been developed to predict mortality after intensive care unit (ICU) admission in medical and surgical patients. However, a similar tool specific to cardiac surgical patients with prolonged ICU duration does not exist. The purpose of the current study was to identify independent perioperative predictors of operative mortality among cardiac surgical patients with prolonged ICU duration. STUDY
DESIGN: From 2003 to 2008, a total of 13,105 cardiac surgical patients with ICU durations >48 hours were identified within a statewide database. Perioperative factors, including Society of Thoracic Surgeons Predicted Risk of Mortality, were evaluated. Univariate and multivariate analyses identified significant correlates of operative mortality and their relative strength of association as determined by the Wald chi-square statistic.
RESULTS: Mean patient age was 66.8 ± 11.2 years, median ICU duration was 76.5 hours (range 56.0 to 124.0 hours), and mean Society of Thoracic Surgeons predicted risk of mortality was 4.4% ± 6.2%. Among preoperative and operative factors, intra-aortic balloon pump use, patient age, immunosuppressive therapy, hemodialysis requirement, cardiopulmonary bypass time, and heart failure proved to be the strongest correlates of mortality (all p < 0.05) on risk-adjusted multivariate analysis. Type of cardiac procedure had no significant association with mortality after risk adjustment. Among postoperative complications, cardiac arrest, prolonged mechanical ventilation (>24 hours), and stroke were the strongest predictors of risk-adjusted mortality (all p < 0.001).
CONCLUSIONS: Operative mortality can be predicted by select risk factors for cardiac surgical patients with prolonged ICU duration. Patient age, preoperative intra-aortic balloon pump, postoperative cardiac arrest, prolonged ventilation, and stroke have the strongest association with mortality. Identification of these factors in the perioperative setting can enhance resource use and improve mortality after cardiac surgery. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2013        PMID: 23619318      PMCID: PMC3666554          DOI: 10.1016/j.jamcollsurg.2013.02.028

Source DB:  PubMed          Journal:  J Am Coll Surg        ISSN: 1072-7515            Impact factor:   6.113


  21 in total

1.  The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 3--valve plus coronary artery bypass grafting surgery.

Authors:  David M Shahian; Sean M O'Brien; Giovanni Filardo; Victor A Ferraris; Constance K Haan; Jeffrey B Rich; Sharon-Lise T Normand; Elizabeth R DeLong; Cynthia M Shewan; Rachel S Dokholyan; Eric D Peterson; Fred H Edwards; Richard P Anderson
Journal:  Ann Thorac Surg       Date:  2009-07       Impact factor: 4.330

2.  Short-term prognosis of critically ill surgical patients: the impact of duration of invasive organ support therapies.

Authors:  Christian P Schneider; Jan Fertmann; Johannes Miesen; Hilde Wolf; Claudia Flexeder; Benjamin Hofner; Helmut Küchenhoff; Karl-Walter Jauch; Wolfgang H Hartl
Journal:  J Crit Care       Date:  2011-07-06       Impact factor: 3.425

3.  Long-term survival and functional capacity in cardiac surgery patients after prolonged intensive care.

Authors:  C A Bashour; J P Yared; T A Ryan; M Y Rady; E Mascha; M J Leventhal; N J Starr
Journal:  Crit Care Med       Date:  2000-12       Impact factor: 7.598

4.  Determinants of operative mortality following primary coronary artery bypass surgery.

Authors:  Navid Sadeghi; Sarmad Sadeghi; Zhoobin Abbasi Mood; Abbasali Karimi
Journal:  Eur J Cardiothorac Surg       Date:  2002-02       Impact factor: 4.191

5.  Outcome and cost of prolonged stay in the surgical intensive care unit.

Authors:  G J Becker; G O Strauch; H J Saranchak
Journal:  Arch Surg       Date:  1984-11

6.  Long-term survival and health status after prolonged mechanical ventilation after cardiac surgery.

Authors:  M Engoren; N F Buderer; A Zacharias
Journal:  Crit Care Med       Date:  2000-08       Impact factor: 7.598

7.  Survival, quality of life, and charges in critically III surgical patients requiring prolonged ICU stays.

Authors:  S M Fakhry; K W Kercher; R Rutledge
Journal:  J Trauma       Date:  1996-12

8.  Are there accurate predictors of long-term vital and functional outcomes in cardiac surgical patients requiring prolonged intensive care?

Authors:  Philippe Gersbach; Hendriks Tevaearai; Jean-Pierre Revelly; Pierre Bize; René Chioléro; Ludwig Karl von Segesser
Journal:  Eur J Cardiothorac Surg       Date:  2006-02-28       Impact factor: 4.191

9.  Hospital charges and long-term survival of ICU versus non-ICU patients.

Authors:  J R Parno; D Teres; S Lemeshow; R B Brown
Journal:  Crit Care Med       Date:  1982-09       Impact factor: 7.598

10.  Aortic Valve Replacement for Aortic Stenosis and Concomitant Coronary Artery Bypass: Long-term Outcomes and Predictors of Mortality.

Authors:  Won-Chul Cho; Dong-Gon Yoo; Joon-Bum Kim; Jae-Won Lee; Suk-Jung Choo; Sung-Ho Jung; Cheol-Hyun Chung
Journal:  Korean J Thorac Cardiovasc Surg       Date:  2011-04-14
View more
  3 in total

1.  Risk factors for prolonged intensive care unit stays in patients after cardiac surgery with cardiopulmonary bypass: A retrospective observational study.

Authors:  Xueying Zhang; Wenxia Zhang; Hongyu Lou; Chuqing Luo; Qianqian Du; Ya Meng; Xiaoyu Wu; Meifen Zhang
Journal:  Int J Nurs Sci       Date:  2021-09-07

2.  Comparison between dexmedetomidine and propofol on outcomes after coronary artery bypass graft surgery: a retrospective study.

Authors:  Jie Hu; Bingfeng Lv; Raha West; Xingpeng Chen; Yali Yan; Chen Pac Soo; Daqing Ma
Journal:  BMC Anesthesiol       Date:  2022-02-19       Impact factor: 2.217

3.  Pulmonary artery perfusion versus no pulmonary perfusion during cardiopulmonary bypass in patients with COPD: a randomised clinical trial.

Authors:  Katrine B Buggeskov; Martin M Sundskard; Thomas Jonassen; Lars W Andersen; Niels H Secher; Hanne B Ravn; Daniel A Steinbrüchel; Janus C Jakobsen; Jørn Wetterslev
Journal:  BMJ Open Respir Res       Date:  2016-09-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.